Fibrocytes and progression of fibrotic lung disease: Ready for showtime?

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 12, 2014, Pages 1338-1339

  Moore, Bethany B ^a   Kolb, Martin ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN;

ADOPTIVE TRANSFER; CELL TYPE; DEATH; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; FORCED VITAL CAPACITY; INTERSTITIAL LUNG DISEASE; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION; OCULAR ALBINISM; PATHOGENESIS; FEMALE; HERMANSKI-PUDLAK SYNDROME; HUMAN; MALE; MESENCHYMAL STROMA CELL; PHYSIOLOGY;

FEMALE; HERMANSKI-PUDLAK SYNDROME; HUMANS; MALE; MESENCHYMAL STROMAL CELLS;

EID: 84919361209     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201411-2013ED     Document Type: Editorial

References (13)

1. Seward SL Jr, Gahl WA. Hermansky-Pudlak syndrome: Health care throughout life. Pediatrics 2013;132: 153-160.
2. Trimble A, Gochuico BR, Markello TC, Fischer R, Gahl WA, Lee JK, Kim Y, Burdick MD, Strieter RM, Mehrad B. Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome. Am J Respir Crit Care Med 2014;190: 1395-1401.
3. Moeller A, Gilpin SE, Ask K, Cox G, Cook D, Gauldie J, Margetts PJ, Farkas L, Dobranowski J, Boylan C, et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009;179: 588-594.
4. Mathai SK, Gulati M, Peng X, Russell TR, Shaw AC, Rubinowitz AN, Murray LA, Siner JM, Antin-Ozerkis DE, Montgomery RR, et al. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest 2010;90: 812-823.
5. Tourkina E, Bonner M, Oates J, Hofbauer A, Richard M, Znoyko S, Visconti RP, Zhang J, Hatfield CM, Silver RM, et al. Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: Reversal by caveolin-1 scaffolding domain peptide. Fibrogenesis Tissue Repair 2011;4: 15.
6. Maharaj S, Shimbori C, Kolb M. Fibrocytes in pulmonary fibrosis: A brief synopsis. Eur Respir Rev 2013;22: 552-557.
7. Kleaveland KR, Moore BB, Kim KK. Paracrine functions of fibrocytes to promote lung fibrosis. Expert Rev Respir Med 2014; 8: 163-172.
8. Moore BB, Murray L, Das A, Wilke CA, Herrygers AB, Toews GB. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol 2006;35: 175-181.
9. Madala SK, Edukulla R, Schmidt S, Davidson C, Ikegami M, Hardie WD. Bone marrow-derived stromal cells are invasive and hyperproliferative and alter transforming growth factor-A-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2014;50: 777-786.
10. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH. Bone marrowderived progenitor cells in pulmonary fibrosis. J Clin Invest 2004;113: 243-252.
11. Kleaveland KR, Velikoff M, Yang J, Agarwal M, Rippe RA, Moore BB, Kim KK. Fibrocytes are not an essential source of type I collagen during lung fibrosis. J Immunol 2014;193: 5229-5239.
12. Quan TE, Bucala R. Culture and analysis of circulating fibrocytes. Methods Mol Med 2007;135: 423-434.
13. White ES, Brown KK, Collard HR, Conoscenti CS, Cosgrove GP, Flaherty KR, Leff JA, Martinez FJ, Roman J, Rose D, et al. Open-Access biorepository for idiopathic pulmonary fibrosis. The way forward. Ann Am Thorac Soc 2014;11: 1171-1175.